You just read:

Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to improve FDA review of shared Risk Evaluation and Mitigation Strategies to improve generic drug access

News provided by

U.S. Food and Drug Administration

Nov 08, 2017, 10:48 ET